...
首页> 外文期刊>Polish Archives of Internal Medicine >Notable effect of bromocriptine monotherapy on macroprolactinoma with self-limited cerebrospinal fluid rhinorrhea
【24h】

Notable effect of bromocriptine monotherapy on macroprolactinoma with self-limited cerebrospinal fluid rhinorrhea

机译:溴隐亭单药治疗自体脑脊液鼻漏大泌乳素瘤

获取原文

摘要

2 episodes of unilateral (right) intermittent cere?brospinal fluid (CSF) rhinorrhea lasting about 1month each after 1 month and 2.5 years of bro?mocriptine administration, respectively. Afterbeing informed of the risks, the patient still re?fused the repair of CSF leakage for economic rea?sons. Therefore, he was treated with antibiotics(oral cefdinir, 0.1 g, 3 times daily), in addition tothe recommendation of bed rest and cleaning ofthe nasal cavities. The CSF rhinorrhea stoppedspontaneously. Magnetic resonance imaging re?vealed that the maximum diameter of the pitu?itary adenoma reduced to 2.4 cm (FIGURE 1D–1F) af?ter 3 years of medication. Moreover, the prolactinlevel normalized. The final dose of bromocriptinewas 6.25 mg/d, and CSF rhinorrhea did not recurduring subsequent follow?up visits.
机译:给予溴隐亭治疗1个月和2.5年后,分别有2次单侧(右)间歇性脑脊液鼻漏(CSF),分别持续约1个月。在获悉风险后,患者仍拒绝接受CSF漏气的修复,以寻求经济理由。因此,除了建议卧床休息和清洁鼻腔外,他还接受了抗生素治疗(口服头孢地尼0.1 g,每天3次)。脑脊液鼻漏自发停止。磁共振成像显示垂体腺瘤的最大直径在服药3年后降至2.4 cm(图1D-1F)。此外,催乳素水平正常化。溴隐亭的最终剂量为6.25 mg / d,CSF鼻漏在随后的随访中没有复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号